RBMO Shares New Findings on Cell Number Biopsied During PGT-A
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn:
“This study investigates the effect on diagnostic and clinical outcomes of the number of trophectoderm cells biopsied during blastocyst-stage PGT-A.
The findings suggest that the diagnostic failure rate may be comparable regardless of the number of cells biopsied, after adjustment for potential confounders in multivariable analyses. Minimizing the number of cells biopsied may reduce embryo injury, supporting the need for standardized biopsy protocols that consider both diagnostic yield and embryo preservation.
The authors say their findings emphasize the need for standardized, evidence-based biopsy protocols that consider both diagnostic yield and embryo preservation.
RBMO subscribers can read the full paper from our in-press articles section now.”
Title: Impact of the number of trophectoderm cells biopsied on the quality of preimplantation genetic testing for aneuploidy
Authors: Chiao-Hsin Kung, Che-Min Chen, Ni-Chin Tsai, Yu-Ting Su, Yu-Ju Lin, Fu-Tsai Kung, Kuo-Chung Lan
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 04:19WHO Raises Alarm Over Global Burden of Child Marriage
-
Apr 17, 2026, 04:11Sign Up for Our Latest BFS Insights Webinar – British Fertility Society
-
Apr 17, 2026, 03:43Chantelle Pereira: Endometriosis Paper Highlights Diagnostic Delays and Gaps in Patient Care
-
Apr 17, 2026, 03:35Tal Varsano: Plasma Proteomic Signature of the Human Menstrual Cycle
-
Apr 17, 2026, 03:30Vacancy for a Friendly Senior Embryologist in Berlin, Germany – ESHRE
-
Apr 17, 2026, 03:05Clinical Study Supports Continued IVF After Unsuccessful First Transfer – RBMO
-
Apr 17, 2026, 02:57Standing Together for Black Maternal Health Week – ACOG
-
Apr 16, 2026, 17:24No Difference Between Natural and Artificial Cycles in Endometrium Cases – RBMO
-
Apr 16, 2026, 17:20Marco Zaccaria: Recognizing Innovation in Adenomyosis Treatment